Ortho-McNeil Ultram
Executive Summary
FDA advisory committee discussion of scheduling status for tramadol is rescheduled for April 28. The Drug Abuse Advisory Committee will also evaluate the effectiveness of the independent steering committee in detecting and preventing Ultram abuse. The meeting will take place at the Gaithersburg, Md. Holiday Inn beginning at 8:30 a.m. The meeting was originally scheduled for Feb. 19 but was postponed to give the advisory committee time to review data ("The Pink Sheet" Feb. 16, In Brief). The committee will meet in closed session April 27...